Navigating the regulatory landscape of fast-growing markets | Mexico
Mexico’s population is 126 million – and counting. As healthcare becomes increasingly affordable and accessible to the country’s growing population,…
Congenius
Mexico’s population is 126 million – and counting. As healthcare becomes increasingly affordable and accessible to the country’s growing population,…
Congenius
Brazil stands as a cornerstone of the Latin American healthcare market, but healthcare needs amongst its sizable population are evolving…
Congenius
In September 2024, the FDA published its draft guidance on “Chemical Analysis for Biocompatibility Assessment of Medical Devices” to improve…
Congenius
The Ecodesign for Sustainable Products Regulation (ESPR) has been effective since 18 July 2024. It represents a groundbreaking transformation in…
Congenius
The Corporate Sustainability Due Diligence Directive (CSDDD), formally known as Directive (EU) 2024/1760, is a significant milestone in the European…
Congenius
The Corporate Sustainability Reporting Directive (CSRD) represents a transformative step in sustainability reporting within the European Union. It introduces rigorous…
Congenius
The European Green Deal, adopted in December 2019, is the European Union’s ambitious roadmap to transform Europe into the first…
Congenius
In Part 1 of our two-part whitepaper series on technical documentation: Technical Documentation Essentials we covered an outline of what…
Congenius